Richard C. Pfenniger
Independent DirectorMr. Richard C. Pfenniger, Jr. also known as Rick, is Lead Independent Director of OPKO Health, Inc. Mr. Pfenniger was Independent Director of OPKO Health, Inc. from January 2008. Mr. Pfenniger joined the OPKO Health, Inc. on January 24, 2008. Mr. Pfenniger is Director of GeneDx, Inc. from May 2022. Mr. Pfenniger had been an Independent Director of Asensus Surgical, Inc. (formerly, TransEnterix, Inc.) since April 2005 until August 22, 2024. Mr. Pfenniger serves as Independent Director of Fluent, Inc. since 2022. He serves as Director of GeneDx Holdings Corp. (formerly known as Sema4 Holdings Corp.) since May 2022. He serves as an Independent Director at Cocrystal Pharma, Inc. since May 27, 2021. Mr. Pfenniger served as an Independent Director at BioCardia, Inc. since October 24, 2016 until January 05, 2020. Mr. Pfenniger served as Interim Chief Executive Officer of IntegraMed America, Inc. from January 2013 to June 2013. Mr. Pfenniger served as Interim Chief Executive Officer to Vein Clinics of America, Inc. from May 2014 to February 2015. Mr. Pfenniger served as the Chief Executive Officer of Whitman Education Group Inc. from March 1997 to July 2003 and its President since 2001. He served as the Chief Operating Officer of IVAX LLC from May 1994 to March 1997. Mr. Pfenniger served as the Senior Vice President of Legal Affairs and General Counsel at IVAX LLC from 1989 to May 1994 and Secretary from 1990 to April 1994. Prior to joining IVAX LLC, he was engaged in private law practice. He served as Vice Chairman of Whitman Education Group Inc. from 1997 to July 2003. He has been an Independent Director of GeneDX Holdings, Inc. since January 24, 2008 and serves as its Lead Independent Director. He had been an Independent Director of GP Strategies Corporation since January 2005. He serves as a Director of NAV and NaPro BioTherapeutics, Inc. He served as Director of Wright Investors Service Holdings, Inc. since March 31, 2015 until February 12, 2019. Mr. Pfenniger also serves as the Vice Chairman of the Board of Trustees of the Phillip and Patricia Frost Museum of Science. He serves as a Director of Vein Clinics of America, Inc. and IntegraMed America, Inc. He served as a Director of Whitman Education Group Inc. since 1992 and General Physics Corporation since January 2005. He served as a Director of Cellular Technical Services Co. Inc. since April 12, 2005, IVAX LLC since 2002. He served as a Director of North American Vaccine Inc. since 1992 and Pan Am Corporation since March 8, 1996. Mr. Pfenniger served as Chief Executive Officer and President of Continucare Corporation, a provider of physician services, from October 2003 to December 2011 and the Chairman of Continucare's Board of Directors from September 2002 to December 2011. Mr. Pfenniger served as Chief Operating Officer of IVAX Corporation from 1994 to 1997 and from 1989 to 1994, he served as Senior Vice President-Legal Affairs and General Counsel of IVAX Corporation. Mr. Pfenniger worked as a C. P.A. with Price Waterhouse & Co. Mr. Pfenniger is a Director of financial advisory firm and IntegraMed. Mr. Pfenniger holds a Juris Doctor degree from the University of Florida and a Bachelor of Business Administration degree from Florida Atlantic University.
Positions
- Company NameFluent, Inc.Stock CodeFLNTPositionIndependent DirectorColleagues
- DHDonald Huntley PatrickChief Executive Officer
- DHDonald H. MathisChairman of the Board & Lead Independent Director
- RSRyan SchulkeCo-Founder, Chief Strategy Officer & Director
- MCMatthew ConlinCo-Founder, Chief Customer Officer & Director
- RMRyan Macnab PerfitCFO and Principal Financial & Accounting Officer
- JWJeanniey WaldenChief Marketing Officer
- RCRichard C. PfennigerIndependent Director
- BZBarbara Z. Shattuck KohnIndependent Director
- Company NameCocrystal Pharma, Inc.Stock CodeCOCPPositionIndependent DirectorColleagues
- RDRoger D. KornbergCo-Founder, Independent Chairman, Chief Scientist & Chairman of Scientific Advisory Board
- SLSam LeeChief Scientific Officer, Co-Founder & President
- JJJames J. MartinCFO & Corporate Secretary
- JRJames R. SapirsteinChief Executive Officer
- SDSteven D. RubinIndependent Vice Chairman
- RCRichard C. PfennigerIndependent Director
- PFPhillip FrostIndependent Director
- MLMichael LevittMember of Scientific Advisory Board
- Company NameGeneDx Holdings Corp.Stock CodeWGSPositionIndependent DirectorColleagues
- KAKatherine A. StuelandCEO & Director
- KAKeith Arlyn MeisterIndependent Chairman of the Board
- KFKevin FeeleyChief Financial Officer
- BMBryan M. DechairoChief Technology & Innovation Officer
- MAMark A. GardnerPresident
- SVSabrina V. DunbarDirector of Investor Relations & Communications
- JRJoshua RuchIndependent Director
- EMEmily Marine LeproustIndependent Director
